# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-180860
Filing Date
2025-08-14
Accepted
2025-08-14 16:45:18
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | iobt-20250630.htm iXBRL | 10-Q | 2770610
2 | EX-31.1 | iobt-ex31_1.htm | EX-31.1 | 17959
3 | EX-31.2 | iobt-ex31_2.htm | EX-31.2 | 17815
4 | EX-32.1 | iobt-ex32_1.htm | EX-32.1 | 10286
5 | EX-32.2 | iobt-ex32_2.htm | EX-32.2 | 10145
6 | GRAPHIC | img135872921_0.jpg | GRAPHIC | 85197
7 | GRAPHIC | img135872921_1.jpg | GRAPHIC | 279215
| Complete submission text file | 0001193125-25-180860.txt |  | 10731687

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | iobt-20250630.xsd | EX-101.SCH | 1196079
82 | EXTRACTED XBRL INSTANCE DOCUMENT | iobt-20250630_htm.xml | XML | 1655078

Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41008 | Film No.: 251220347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)